Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

26.55
+0.37001.41%
Post-market: 26.47-0.0800-0.30%19:24 EST
Volume:1.02M
Turnover:27.01M
Market Cap:1.14B
PE:56.33
High:26.80
Open:26.18
Low:25.48
Close:26.18
52wk High:27.64
52wk Low:18.17
Shares:43.02M
Float Shares:37.84M
Volume Ratio:0.96
T/O Rate:2.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.4713
EPS(LYR):-2.1529
ROE:2.90%
ROA:2.89%
PB:1.57
PE(LYR):-12.33

Loading ...

Pacira BioSciences (PCRX): Examining Valuation After Recent Share Price Momentum and Strategic Developments

Simply Wall St.
·
Nov 08

Pacira BioSciences Is Maintained at Buy by Truist Securities

Dow Jones
·
Nov 08

Stock Track | Pacira Pharmaceuticals Soars 5.59% Pre-Market on Analyst's Buy Rating

Stock Track
·
Nov 07

Pacira Pharmaceuticals (PCRX) Gets a Buy from Truist Financial

TIPRANKS
·
Nov 07

Pacira reports Q3 EPS 70c, consensus 65c

TIPRANKS
·
Nov 07

Pacira BioSciences Q3 Adj. EPS $0.70 Beats $0.65 Estimate, Sales $179.516M Miss $182.552M Estimate

Benzinga
·
Nov 07

Pacira Biosciences Q3 Cash & Investments USD 246.3 Million

THOMSON REUTERS
·
Nov 07

Pacira BioSciences Completes Enrollment in Phase 2 Trial for PCRX-201 Osteoarthritis Gene Therapy

Reuters
·
Nov 05

Pacira Biosciences Concludes Patient Enrollment in Part a of Phase 2 Study Evaluating Safety and Efficacy of Pcrx-201 for the Treatment of Osteoarthritis of the Knee

THOMSON REUTERS
·
Nov 05

Pacira Biosciences Inc expected to post earnings of 65 cents a share - Earnings Preview

Reuters
·
Nov 05

Amacathera: Gets US$5 Mln Upfront and up to US$225 Mln in Potential Future Milestone Payments With Pacira Biosciences

THOMSON REUTERS
·
Nov 04

Amacathera Signs Exclusive Global Licensing Agreement With Pacira Biosciences for up to US$230 Million, Validating Its Tunable Drug Delivery Platform

THOMSON REUTERS
·
Nov 04

Pacira BioSciences Secures Exclusive License for Long-Acting Analgesic from AmacaThera

Reuters
·
Nov 04

Pacira Biosciences Enters Exclusive License Agreement With Amacathera for Its Novel Long-Acting Analgesic for Postsurgical Pain Control

THOMSON REUTERS
·
Nov 04

Pacira Biosciences Inc - Phase 2 Program for Amt-143 Expected to Begin in 2026

THOMSON REUTERS
·
Nov 04

Pacira Biosciences Inc - Amacathera to Receive $5 Mln Upfront Payment

THOMSON REUTERS
·
Nov 04

Pacira Biosciences Inc. to Release Third Quarter 2025 Financial Results

Reuters
·
Oct 30

Pacira BioSciences Reports Three-Year Data Showing Sustained Efficacy of PCRX-201 Gene Therapy for Knee Osteoarthritis

Reuters
·
Oct 28

BRIEF-Pacira Biosciences Inc - Receives Paragraph Iv Notice From Qilu Pharmaceutical

Reuters
·
Oct 27

Pacira Biosciences Inc - Qilu Alleges 18 Exparel Patents Invalid or Unenforceable

THOMSON REUTERS
·
Oct 27